Cart
sales@molnova.com
ZL0590
CAS No. 2230496-99-6
ZL0590 ( —— )
Catalog No. M28525 CAS No. 2230496-99-6
ZL0590 is an effective and selective inhibitor of BD1-BRD4 (IC50 = 90 nM) with anti-inflammatory activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 177 | Get Quote |
|
| 10MG | 282 | Get Quote |
|
| 25MG | 480 | Get Quote |
|
| 50MG | 691 | Get Quote |
|
| 100MG | 972 | Get Quote |
|
| 500MG | 1944 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameZL0590
-
NoteResearch use only, not for human use.
-
Brief DescriptionZL0590 is an effective and selective inhibitor of BD1-BRD4 (IC50 = 90 nM) with anti-inflammatory activities.
-
DescriptionZL0590 is an effective and selective inhibitor of BD1-BRD4 (IC50 = 90 nM) with anti-inflammatory activities.
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2230496-99-6
-
Formula Weight512.6
-
Molecular FormulaC23H27F3N4O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS(=O)(=O)(N1[C@H](CN2CCOCC2)CCC1)C3=CC=C(NC(NC4=CC=C(C(F)(F)F)C=C4)=O)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
RVX-208
RVX-208 is a potent BET bromodomain inhibitor with IC50 of 0.510 μM for BD2 in a cell-free assay, about 170-fold selectivity over BD1. Phase 2.
-
CBP/EP300-IN-1
CBP/EP300-IN-1 is a CBP/EP300 bromodomain inhibitor.
-
BRM/BRG1 ATP Inhibit...
BRM/BRG1 ATP Inhibitor-2 is an inhibitor of BRG1/BRM ATPase and can be used in studies about the treatment of BAF-related disorders.
